Related Experiment Video
Updated: Aug 6, 2025
Direct Observation of Phagocytosis and NET-formation by Neutrophils in Infected Lungs using 2-photon Microscopy
Published on: June 2, 2011
A Case of Microscopic Polyangiitis Complicated by Mucormycosis: A Dangerous Balancing Act
1Division of Internal Medicine, Montefiore Medical Center, Bronx, USA.
Abstract:
Microscopic polyangiitis (MPA) is a rare antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis marked by renal involvement, which often leads to rapidly progressive glomerulonephritis. Immunosuppressive treatment is necessary to prevent irreparable organ damage. On the other hand, mucormycosis is a rare and devastating opportunistic fungal infection with a high mortality rate in both immunosuppressed and immunocompetent individuals. It requires a high index of suspicion at the time of diagnosis since any delay in treatment may lead to severe morbidity or death. Here, we present the case of a diabetic patient diagnosed with MPA who received partial induction treatment, subsequently developed mucormycosis, survived, yet required continued immunosuppressive treatment for active MPA while imaging was concerning for a persistent mucormycosis infection. This case highlights the barriers to early mucormycosis detection specific to vasculitis patients, mucormycosis considerations unique to the rheumatologic population, and discusses how to balance immunosuppressive treatment in the setting of a deadly opportunistic infection.
Insights
Microscopic polyangiitis patients on immunosuppression face risks of invasive fungal infections like mucormycosis. Balancing treatment for both conditions is critical for survival and preventing organ damage.
Area of Science:
- Rheumatology
- Infectious Diseases
- Nephrology
Background:
- Microscopic polyangiitis (MPA) is a rare ANCA-associated vasculitis often causing glomerulonephritis, necessitating immunosuppressive therapy.
- Mucormycosis is a severe opportunistic fungal infection with high mortality, particularly in immunocompromised individuals.
Observation:
- A diabetic patient with MPA developed mucormycosis during partial immunosuppressive induction therapy.
- The patient survived mucormycosis but required ongoing immunosuppression for active MPA, complicated by persistent fungal infection concerns.
Findings:
- This case illustrates challenges in early mucormycosis detection in vasculitis patients.
- It highlights unique mucormycosis considerations within rheumatologic populations.
- Balancing immunosuppression for MPA against a life-threatening fungal infection poses significant clinical dilemmas.
Implications:
- Early detection and management strategies for mucormycosis in MPA patients are crucial.
- Careful consideration of immunosuppressive regimens is needed to mitigate risks of opportunistic infections.
- This case underscores the complex interplay between autoimmune diseases and invasive fungal infections.
Related Concept Videos
01:28Fungal Phylum Microsporidia
01:29Fungal Group Zygomycota
01:28Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...